Substituted 1,3-dioxanes useful as PPAR modulators
US9260406B2 · kind B2 · utility
0Cited by
18References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 7, 2013 |
| Grant date | Feb 16, 2016 |
| Priority date | — |
| Expiry date | Mar 7, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D407/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Specifically useful stereoisomers of 1,3-dioxane derivatives are described and their use in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and infections as well as their use in the treatment of a disease related to TP, such as cardiovascular diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.